You just read:

Caris Life Sciences Introduces Research Showing Time-To-Next Treatment as Effective Surrogate Outcome Measure in Retrospective Study of 4729 Cancer Patients Undergoing Panomic Profiling

News provided by

Caris Life Sciences

07 Jun, 2016, 08:45 ET